Scientists develop new gene therapy for deafness
Replacing defective genes that cause gradual hearing loss in mice is successful and could lead to treatment for human babies with similar mutations.
Replacing defective genes that cause gradual hearing loss in mice is successful and could lead to treatment for human babies with similar mutations.
Scientists at two Israeli universities unlock a vital part of the puzzle into what causes deafness.
TAU model provides a platform to test therapeutic approaches in order to prevent hearing loss before it occurs.